(Date:11/18/2009)...., Nov. 18 Sangamo BioSc... data from the University of Pennsylvania investig...inc finger nuclease (ZFN) based product, SB-728-T,...isclosed on the internet. ,, Data were presente...vania School of Medicine from a single subject tre...
(Date:11/18/2009)...Nov. 18 Masimo (Nasdaq...nd Measure-Through Motion and Low-Perfusion pulse ...Uni.H.A., one of the largest healthcare Group Purc... multi-year purchasing agreement for "gold standar...ent offers preferred contract pricing to Uni.H.A.,...
(Date:11/18/2009)...ov. 18 Reportlinker.com announces ...its catalogue. ,, Biotechnology Reagents - A ...ortlinker.com/p0164375/Biotechnology-Reagents---A-...re&utm_medium=pr&utm_campaign=prnewswire ...chemical compounds used in a range of biotech rela...
(Date:11/18/2009)...romega Corporation and SwitchGear Genomics announc...teractions. , Madison, WI...tion and SwitchGear Genomics announce a novel meth...sults of a study using the HaloCHIP™ System ...e ability to correlate DNA binding events to trans...
Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2...,(NASDAQ: AMRND ) today announced that, at a Gene...ed a 1 for 10 reverse split of each of its Ordinar... the close of business,yesterday, January 17, 2008...ive Officer, commented,"We are very pleased to rep...lders approved the one-for-ten reverse stock split...
...-adoption clinical evaluation of ...eans that all the population is susceptible to ...d concerns over "second wave" of vCJD in individua...ion times - P-Capt(R) prion reduction filter sti...potential transmission of the disease in blood, - ...
...a, Irvine researchers have identified a gene that ...ebral cortex, a finding that could lead to stem ce...such as stroke and Alzheimers. , Dr. Edwin Monuki...gues in the departments of Pathology & Laboratory ...at a gene called Lhx2 serves as the long-sought co...
Other Biology Technology:Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 2Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 3Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 4Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 5Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 6Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 7Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 8Amarin Provides Business Update and Announces Implementation of Reverse Stock Split 9ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 2ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 3ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 4ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 5Discovery of 'creator' gene for cerebral cortex points to potential stem cell treatments 2GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
GIBCO Versene 1:5;000 (1X); liquid from Invitrogen
Immunochemistry 1 & 2 from Promega
... • This book describes current strategies and...tibodies, the use of antibodies in immunoassays, t... latest ELISA techniques including amplification s...face molecules (cell-ELISA and ELISPOT procedures)...
Biology Products: